Mr Josephus Reynes, - Speech-Language Pathologist in Jersey City, NJ

Mr Josephus Reynes, is a Speech-language Pathologist based in Jersey City, New Jersey. Mr Josephus Reynes is licensed to practice in New York (license number 1411647) and his current practice location is 54 Towers St, Jersey City, New Jersey. He can be reached at his office (for appointments etc.) via phone at (917) 226-1181.

NPI number for Mr Josephus Reynes is 1013250190 and his current mailing address is 54 Towers St., Jersey City, New Jersey. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1013250190.

Contact Information

Mr Josephus Reynes,
54 Towers St,
Jersey City, NJ 07305-1005
(917) 226-1181
Not Available



Healthcare Provider's Profile

Full NameMr Josephus Reynes
GenderMale
SpecialitySpeech-language Pathologist
Location54 Towers St, Jersey City, New Jersey
Accepts Medicare AssignmentsDoes not participate in Medicare Program. He may not accept medicare assignment.
  NPI Data:
  • NPI Number: 1013250190
  • Provider Enumeration Date: 03/27/2013
  • Last Update Date: 03/27/2013

Medical Identifiers

Medical identifiers for Mr Josephus Reynes such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1013250190NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
235Z00000XSpeech-language Pathologist 1411647 (New York)Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mr Josephus Reynes is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Mr Josephus Reynes,
54 Towers St.,
Jersey City, NJ 07305

Ph: (917) 226-1181
Mr Josephus Reynes,
54 Towers St,
Jersey City, NJ 07305-1005

Ph: (917) 226-1181

News Archive

First patient included in the phase II study of Amphinex® in head and neck cancer patients

PCI Biotech (PCIB) the Norwegian biopharmaceutical company, reported today that the first patient has been included in the phase II study of Amphinex in combination with the cytotoxic agent bleomycin in head and neck cancer patients, called the ENHANCE study. The first patient was included at the National Center for Tumor Diseases (NCT), University Hospital Heidelberg, Germany. NCT is a joint project of the German Cancer Research Center (DKFZ), Heidelberg University Hospital, Thoraxklinik Heidelberg and Deutsche Krebshilfe (German Cancer Aid).

ZOTEN nanoparticles can help develop natural immunity against genital herpes

An effective vaccine against the virus that causes genital herpes has evaded researchers for decades. But now, researchers from the University of Illinois at Chicago working with scientists from Germany have shown that zinc-oxide nanoparticles shaped like jacks can prevent the virus from entering cells, and help natural immunity to develop.

Reviewing G-FINDER report findings

Nick Chapman, a policy analyst at Policy Cures, writes in a guest post on the Global Health Technologies Coalition's "Breakthroughs" blog about "the results of the latest G-FINDER survey on global funding of [research and development (R&D)] for neglected diseases."

MSU study: Despite early treatment, HIV still attacks children's brains

The vast majority of children living with HIV today are in sub-Saharan Africa. While early antiretroviral therapy, or ART, has ensured less deadly outcomes for children living with and exposed to HIV, studies show the virus still may affect the brain.

Intervention strategies to curb spread of pandemic flu

Mathematicians, biostaticians and public health officials from Canada, Mexico and the United States will gather at Arizona State University this week to focus on understanding, possibly mitigating the spread of the H1N1 flu virus. They are planning to take up the challenge of proposing science-based strategies that can slow the spread of pandemic flu.

Read more News

› Verified 2 days ago


Speech-Language Pathologist in Jersey City, NJ

Speech Quest Jcny
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 581 Jersey Ave, Jersey City, NJ 07302
Phone: 201-381-1607    Fax: 201-216-9171
Alisha Beth Cipollone, CCC-SLP
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 299 Pavonia Avenue, 1-3, Jersey City, NJ 07302
Phone: 917-478-3042    
Maria Pasahol, MA, CCC-SLP
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 35 Journal Square Plz, Jersey City, NJ 07306
Phone: 551-247-1306    
Katie Michele Hanily, M.A. CF-SLP
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 35 Journal Square Plz Ste 610, Jersey City, NJ 07306
Phone: 551-247-1306    
Sensorykids,llc
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 278 Monmouth St, Jersey City, NJ 07302
Phone: 201-324-1700    
Elizabeth Bornstein,
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 263 Whiton St Apt 2, Jersey City, NJ 07304
Phone: 908-625-2550    Fax: 908-232-3583

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.